News

Does JenaValve’s New Designation Signal the Start of Another Strong Year for TAVR?

2019 was a busy year for the transcatheter aortic valve replacement market. JenaValve’s Breakthrough Device Designation from FDA builds on that momentum and could help make 2020 a stellar year for TAVR.

Allurion Kicks It up a Notch with New Funding and Personnel

The Obesity treatment company has raised $34 million to help it in its bid to get the Elipse Balloon for weight loss approved. Allurion is also seeking to use the funding to expand its presence outside the U.S.

Abbott's New Designation Helps Advance its Position in LVAD Market

The Abbott Park, IL-based company has won a nod from FDA for a less invasive surgical approach for the HeartMate 3 Left Ventricular Assist Device. The firm’s rival, Dublin-based Medtronic won the same designation for the HVAD in 2018.

AtriCure Completes Patient Enrollment for aMAZE Trial

The Mason, OH-based company inherited Lariat, the device being evaluated in the aMAZE clinical trial, when it acquired SentreHeart for $300 million last year.

Guided Therapeutics Begins 2020 with Renewed FDA Approval Bid

The Norcross, GA-based company is developing the LuViva Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care.

Using Imaging for Early Intervention After a Heart Attack

A new study shows that a radiotracer can effectively image fibroblast activation after a heart attack. This could lead to improved outcomes for heart attack patients.

Laser System Can Remotely Capture Images Inside Your Body

MIT researchers say the technique may help remotely image and assess health of infants, burn victims, and accident survivors in hard-to-reach places.

Medtech in a Minute: SFA Competition, Check-Cap Inches Toward US Market, and More

Researchers find broader benefits of a common cardiac blood test, and a new capsule-based polyp detection system eliminates the need for bowl prep. But first, is PQ Bypass ready to go head-to-head with Gore?

Illumina and PacBio Call it Quits on $1.2B Merger

San Diego, CA-based Illumina made plans to acquire Pacific Biosciences in November of 2018. However, the Federal Trade Commission challenged the deal late last year, saying the merger could have the potential to create a monopoly in the next-generation sequencing market.

New Polymers Bend, Twist, And Grab

In the past materials tended to remain static. More and more, researchers are developing dynamic materials that can change their shape on the fly. One of the latest breakthroughs in this type of technology comes from researchers at Georgia Institute of Technology (Georgia Tech) and Ohio State...

Blood Test Gives Greater Insight on Heart Attack Risk After Surgery

A new study conducted by researchers from Hamilton Health Sciences shows a blood test done before surgery can predict who will experience adverse cardiovascular outcomes after most types of procedures.

Check-Cap is Inching Toward the U.S. Market with Positive Pilot Results

Check-Cap Ltd. is reporting positive results from a pilot study of its C-Scan System. The Isfiya, Israel-based company’s C-Scan System is a preparation-free ingestible scanning capsule-based system for the prevention of colorectal cancer through the detection of precancerous polyps. Results from...